samatasvir

an antiviral agent that inhibits NS5A protein from hepatitis C virus; structure in first source

Also Known As:

IDX719

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

1.	Infections 05/01/2014 - "Samatasvir 25-100mg monotherapy for 3days was well tolerated and induced a rapid and profound reduction in plasma HCV RNA in subjects infected with HCV genotype 1-4. Samatasvir is being evaluated in combination with other direct-acting antiviral agents in subjects with HCV infection."
2.	Hepatitis C 05/01/2014 - "Samatasvir is a pan-genotypic inhibitor of the hepatitis C (HCV) non-structural protein 5A (NS5A). "

1.	RNA (Ribonucleic Acid)
2.	Proteins (Proteins, Gene)
3.	Antiviral Agents (Antivirals)